Loading…

Pharmaceutical & Biotech

Novartis Shifts Sights to Eye Care Giant Alcon with $50 Billion Buyout Plan

Starting off the New Year with a bang, Swiss drugmaker Novartis AG (NYSE:NVS) (Basel, Switzerland) has launched what has transformed into a nearly $50 billion deal...

Released Wednesday, January 06, 2010

Novartis Shifts Sights to Eye Care Giant Alcon with $50 Billion Buyout Plan

Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Starting off the New Year with a bang, Swiss drugmaker Novartis AG (NYSE:NVS) (Basel, Switzerland) has launched what has transformed into a nearly $50 billion deal to acquire Alcon (NYSE:ACL) (Fort Worth, Texas), the U.S. eye care company. The deal, reportedly the largest in Swiss history, has grown from Novartis' initial $10.4 billion Alcon investment last year with Alcon's parent company, Swiss food maker Nestle (Vevey, Switzerland). The buy will instantly elevate Novartis in the burgeoning eye care industry.

The latest incarnation of the Alcon deal has Novartis buying the remaining majority stake from Nestle for $28.1 billion, which in turn will raise its own stake to 77%. To complete the deal, Novartis is offering up to $11.3 billion of its shares to Alcon's minority shareholders for the remaining 23% of the company. The total cost in cash and stock will $49.8 billion.

With the transaction, Novartis will be able to offer a product line covering an estimated 70% of the eye-care sector. The company will gain consumer eye-care, pharmaceutical and surgical business lines for which Alcon reported $6.3 billion in 2008 sales. Assuming the deal goes through in mid-2010, the Alcon lines will merge with Ciba Vision, Novartis' existing eye-care business, to operate as one division.

Nestle's acquisition of Alcon in 1977 for $280 million has proven to be a shrewd move as analysts estimate that the company has multiplied its initial investment by more than 140 times over the past three decades. Robert Alexander and William Conner founded Alcon in 1945 as a pharmacy in Fort Worth, Texas, with a focus on sterile ophthalmic products. The company name is a combination of the first parts of each of the founder's last names.

Industrial Info Resources (IIR) is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy related markets. For more than 26 years, Industrial Info has provided plant and project opportunity databases, market forecasts, high resolution maps, and daily industry news.
/news/article.jsp false

Share This Article

Want More IIR News Intelligence?


Make us a Preferred Source on Google to see more of us when you search.

Add Us On Google

Please verify you are not a bot to enable forms.

What is 21 + 2?

Ask Us

Have a question for our staff?

Submit a question and one of our experts will be happy to assist you.

By submitting this form, you give Industrial Info permission to contact you by email in response to your inquiry.

A glowing computer chip is placed on a dark blue circuit board. Bright blue lines and nodes create a futuristic, technological ambiance.

Forecasts & Analytical Solutions

Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.

Explore Our Solutions
Dimly lit data center with rows of towering black server racks, glowing blue lights, and a sleek, futuristic ambiance.

PECWeb Global Market Intelligence Platform

Identify opportunities, anticipate change, and execute with confidence. PECWeb connects the industrial intelligence you need, from projects and assets to operational events, all in one platform.

Discover Pecweb

Get notifications from IIR News Intelligence

Click 'Sign Up' then 'Allow'